These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 15928417)

  • 21. Intra-dermal administration of rabies vaccines in developing countries: at an affordable cost.
    Verma R; Khanna P; Prinja S; Rajput M
    Hum Vaccin; 2011 Jul; 7(7):792-4. PubMed ID: 21734465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A single center, open label study of intradermal administration of an inactivated purified chick embryo cell culture rabies virus vaccine in adults.
    Recuenco S; Warnock E; Osinubi MOV; Rupprecht CE
    Vaccine; 2017 Aug; 35(34):4315-4320. PubMed ID: 28688782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of safety and immunogenicity of 2 WHO prequalified rabies vaccines administered by one week, 4 site intra dermal regimen (4-4-4-0-0) in animal bite cases.
    Narayana A; Manoharan A; Narayan MS; Kalappa SM; Biligumba G; Haradanahalli R; Anand AM
    Hum Vaccin Immunother; 2015; 11(7):1748-53. PubMed ID: 26083005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Economical multi-site intradermal regimen with purified chick embryo cell vaccine (Rabipur) prevents rabies in people bitten by confirmed rabid animals.
    Madhusudana SN; Anand NP; Shamsundar R
    Int J Infect Dis; 2002 Sep; 6(3):210-4. PubMed ID: 12718837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rabies pre-exposure vaccination of children with purified chick embryo cell vaccine (PCECV).
    Malerczyk C; Vakil HB; Bender W
    Hum Vaccin Immunother; 2013 Jul; 9(7):1454-9. PubMed ID: 23571224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rabies neutralizing antibody after 2 intradermal doses on days 0 and 21 for pre-exposure prophylaxis.
    Wongsaroj P; Udomchaisakul P; Tepsumethanon S; Khawplod P; Tantawichien T
    Vaccine; 2013 Mar; 31(13):1748-51. PubMed ID: 23370149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Purified chick embryo cell rabies vaccine: economical multisite intradermal regimen for post-exposure prophylaxis.
    Suntharasamai P; Warrell MJ; Viravan C; Chanthavanich P; Looareesuwan S; Supapochana A; Supanaranond JK; Chittamas S; Bijok U; Warrell DA
    Epidemiol Infect; 1987 Dec; 99(3):755-65. PubMed ID: 3428378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intradermal post-exposure rabies vaccination with purified Vero cell rabies vaccine: Comparison of a one-week, 4-site regimen versus updated Thai Red Cross regimen in a randomized non-inferiority trial in the Philippines.
    Quiambao BP; Ambas C; Diego S; Bosch Castells V; Korejwo J; Petit C; Houillon G
    Vaccine; 2019 Apr; 37(16):2268-2277. PubMed ID: 30890382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparative study on the safety and immunogenicity of Purified duck embryo vaccine [corrected] (PDEV, Vaxirab) with purified chick embryo cell vaccine (PCEC, Rabipur) and purifed vero cell rabies vaccine (PVRV, Verorab).
    Ashwathnarayana DH; Madhusudana SN; Sampath G; Sathpathy DM; Mankeshwar R; Ravish HH; Ullas PT; Behra TR; Sudarshan MK; Gangaboraiah ; Shamanna M
    Vaccine; 2009 Dec; 28(1):148-51. PubMed ID: 19818720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenicity of intradermal vaccination of Japanese rabies vaccine for preexposure immunization following WHO recommendation.
    Yanagisawa N; Takayama N; Mannen K; Nakayama E; Suganuma A
    J Infect Chemother; 2012 Feb; 18(1):66-8. PubMed ID: 21809060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunogenicity and safety of WHO-approved TRC-ID regimen with a chromatographically purified Vero cell rabies vaccine with or without rabies immunoglobulin in children.
    Angsuwatcharakon P; Khomvilai S; Limsuwun K; Ratananpinit N; Khamchat A; Sanitnai T; Tantawichien T
    Expert Rev Vaccines; 2018 Feb; 17(2):185-188. PubMed ID: 29285961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A three-year clinical study on immunogenicity, safety, and booster response of purified chick embryo cell rabies vaccine administered intramuscularly or intradermally to 12- to 18-month-old Thai children, concomitantly with Japanese encephalitis vaccine.
    Pengsaa K; Limkittikul K; Sabchareon A; Ariyasriwatana C; Chanthavanich P; Attanath P; Malerczyk C
    Pediatr Infect Dis J; 2009 Apr; 28(4):335-7. PubMed ID: 19333080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunogenicity of a modified intradermal pre-exposure rabies vaccination schedule using a purified chick embryo cell vaccine: an observational study.
    Lau CL; Hohl N
    Travel Med Infect Dis; 2013; 11(6):427-30. PubMed ID: 24135254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of safety and immunogenicity of purified chick embryo cell vaccine using Zagreb and Essen regimens in patients with category II exposure in China.
    Hu Q; Liu MQ; Zhu ZG; Zhu ZR; Lu S
    Hum Vaccin Immunother; 2014; 10(6):1645-9. PubMed ID: 24632727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Comparative Study on the Adverse Reactions of Purified Chick Embryo Cell Vaccine (PCECV) and Purified Vero Cell Rabies Vaccine (PVRV).
    Ramezankhani R; Shirzadi MR; Ramezankhani A; Poor Mozafary J
    Arch Iran Med; 2016 Jul; 19(7):502-7. PubMed ID: 27362245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of two intradermal vaccination regimens using purified chick embryo cell vaccine for post-exposure prophylaxis of rabies.
    Madhusudana SN; Anand NP; Shamsundar R
    Natl Med J India; 2001; 14(3):145-7. PubMed ID: 11467142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and immunogenicity of a new purified vero cell rabies vaccine (PVRV) administered by intramuscular and intradermal routes in healthy volunteers.
    Kulkarni PS; Sapru A; D'costa PM; Pandit A; Madhusudana SN; Yajaman AB; Mangrule S; Gunale B; Bavdekar AR
    Vaccine; 2013 May; 31(24):2719-22. PubMed ID: 23583817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pre-exposure prophylaxis against rabies in children: safety of purified chick embryo cell rabies vaccine (Vaxirab N) when administered by intradermal route.
    Ravish HS; Srikanth J; Ashwath Narayana DH; Annadani R; Vijayashankar V; Undi M
    Hum Vaccin Immunother; 2013 Sep; 9(9):1910-3. PubMed ID: 23787889
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunogenicity, safety and antibody persistence of a purified vero cell cultured rabies vaccine (Speeda) administered by the Zagreb regimen or Essen regimen in post-exposure subjects.
    Shi N; Zhang Y; Zheng H; Zhu Z; Wang D; Li S; Li Y; Yang L; Zhang J; Bai Y; Lu Q; Zhang Z; Luo F; Yu C; Li L
    Hum Vaccin Immunother; 2017 Jun; 13(6):1-8. PubMed ID: 28121231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A pilot study on intradermal vaccination of Japanese rabies vaccine for pre-exposure immunization.
    Shiota S; Khawplod P; Ahmed K; Mifune K; Nishizono A
    Vaccine; 2008 Nov; 26(50):6441-4. PubMed ID: 18804510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.